A01K 2267/0312
Animal model for alzheimer's disease
Official title: Animal model for Alzheimer's disease
A01K2267/0312 (Animal model for alzheimer's disease) appears on 214 US grants and 350 published applications in this corpus.
Search patents in A01K- Granted patents
- 214
- Published applications
- 350
- Assignees
- 248
- Inventors
- 797
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 12 | 0 |
| 2000 | 4 | 0 |
| 2001 | 11 | 2 |
| 2002 | 9 | 22 |
| 2003 | 12 | 30 |
| 2004 | 10 | 19 |
| 2005 | 4 | 25 |
| 2006 | 9 | 19 |
| 2007 | 17 | 18 |
| 2008 | 4 | 16 |
| 2009 | 8 | 16 |
| 2010 | 10 | 12 |
| 2011 | 8 | 18 |
| 2012 | 6 | 5 |
| 2013 | 3 | 8 |
| 2014 | 6 | 5 |
| 2015 | 5 | 3 |
| 2016 | 2 | 10 |
| 2017 | 5 | 4 |
| 2018 | 4 | 16 |
| 2019 | 5 | 16 |
| 2020 | 7 | 11 |
| 2021 | 3 | 15 |
| 2022 | 9 | 15 |
| 2023 | 4 | 13 |
| 2024 | 4 | 16 |
| 2025 | 5 | 11 |
| 2026 | 7 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient18 Aug 2026US 12,708,657 B2Amyloid Solution Inc.
- Tissue selective transgene expression28 Jul 2026US 12,692,516 B2Encoded Therapeutics, Inc.
- Alzheimers disease animal model and use thereof26 May 2026US 12,635,675 B2Tsinghua University
- Application of TPK as a target in Alzheimer's disease17 Mar 2026US 12,575,549 B2Shanghai Raising Pharmaceutical Co., Ltd.
- Oligonucleotides for controlling tau splicing, and uses thereof10 Mar 2026US 12,570,974 B2Aichi Medical University
- Use of interleukin 27 protein in preparation of product for treating and/or delaying alzheimer's disease25 Jun 2026US 2026/0176315 A1Guangdong Jiantebo Biotechnology Co., Ltd.
- Compositions and methods using reelin in alzheimer's disease21 May 2026US 2026/0139017 A1Banner Health
- Compositions and methods to treat alzheimer's disease and other brain diseases9 Apr 2026US 2026/0098268 A1Board of Regents, The University of Texas System
- Mouse Model For Alzheimer's Disease And Neurofibrillary Pathology26 Mar 2026US 2026/0083107 A1
- Methods for treating alzheimer's disease29 Jan 2026US 2026/0027157 A1The Regents of the University of California
Most cited
By later US patents
- Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease201US 5,387,742 AScios Nova Inc. · 1995
- Methods for monitoring cellular processing of .beta.-amyloid precursor protein167US 5,441,870 AAthena Neurosciences, Inc. · 1995
- Transgenic animals harboring APP allele having swedish mutation142US 5,612,486 AAthena Neurosciences, Inc. · 1997
- Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease122US 5,877,399 ARegents of the University of Minnesota · 1999
- Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP114US 5,721,130 AAthena Neurosciences, Inc. · 1998